Purpose. The most common illness caused by Streptococcus pyogenes (Group A streptococcus; GAS) is acute pharyngitis. It has been reported that a small percentage of patients experience recurrent GAS pharyngitis after 10 days of treatment with oral amoxicillin. The aim of this study was to clarify whether recurrent GAS pharyngitis is reactivation caused by the primary strain remaining at the infection site, or if the reinfection is caused by newly acquired strains.
INTRODUCTION
Streptococcus pyogenes (Group A streptococcus; GAS) is a gram-positive human pathogen causing a diverse range of diseases. GAS causes both mild infections, such as pharyngitis and impetigo, and life-threatening diseases, such as toxic shock syndrome and necrotizing fasciitis [1] . The most common illness caused by GAS is acute pharyngitis, which often occurs among infants and school-aged children. Approximately 15-30 % of pediatric pharyngitis results from infection with GAS [2] . The incubation period for streptococcal pharyngitis is 2-5 days [3] . GAS pharyngitis can also result in secondary sequelae, such as acute glomerulonephritis and rheumatic fever [1] . Acute glomerulonephritis appears with the symptoms of hematuria and proteinuria 10 days on average after the GAS pharyngitis, or 20 days after impetigo. Rheumatic fever occurs 20 days on average after the GAS pharyngitis, together with inflammation of the joints, heart and skin. For a definitive diagnosis, it is necessary to isolate organisms from the specimen obtained by swabbing the tonsils. If done correctly, a throat culture on a blood agar plate shows 90-95 % sensitivity for the diagnosis of GAS pharyngitis [4, 5] . Several rapid diagnostic tests are also useful to detect GAS antigens in the specimen.
Although most patients with GAS pharyngitis recover spontaneously within 4-7 days [6] , antimicrobial therapy is recommended for all patients because it prevents acute rheumatic fever, shortens the clinical course, decreases the risk of transmission, and decreases the risk of suppurative sequelae [3, 5] . According to the guidelines of the American Academy of Pediatrics and the Infectious Diseases Society of America, penicillin or amoxicillin administered for 10 days is the recommended treatment of first choice for GAS pharyngitis [3, 5] . There have been no reports of penicillin-resistant GAS clinical isolates [5] , but it was previously reported that approximately 10 to 30 % of patients became asymptomatic carriers of GAS even after 10 days of penicillin therapy. Moreover, a small percentage of these patients experiences recurrent pharyngitis caused by GAS, with intermittent asymptomatic periods ranging from weeks to months [7] [8] [9] [10] . It is still unclear, however, whether recurrent pharyngitis is due to reactivation caused by the primary strain remaining at the infection site, or if the reinfection is caused by a newly acquired strain from the community, making it difficult for pediatricians to decide whether they should choose penicillin again or another antibiotic for the treatment of patients with recurrent GAS pharyngitis.
The GAS strains are classified into more than 80 serotypes, based on their M protein antigenicity. This is called M typing, which is very important in the epidemiological study of GAS infections. M protein is encoded by the emm gene, which harbors a hyper-variable region with the antigen that evokes a human type-specific antibody response [11, 12] . The database of each emm gene sequence became available for public use on the website of the US Centers for Disease Control and Prevention (CDC) (http://www2a.cdc.gov/ncidod/biotech/strepblast.asp), and emm typing is now the most widely used technique to characterise GAS strains [11] . Pulsed-field gel electrophoresis (PFGE) is also used as a molecular epidemiological tool for further discrimination of GAS strains expressing the same M-type [11] . There are also other and new molecular methods for subtyping GAS strains available, in particular Multilocus Sequence Typing (MLST) and Whole Genome Sequence (WGS) typing [13, 14] , but in this study, we used a combination of emm typing and PFGE typing for epidemiological analysis of GAS isolates from patients with pharyngitis.
The aim of this study was to clarify whether recurrent GAS pharyngitis is reactivation or reinfection. We compared the GAS strain that caused initial pharyngitis with the GAS strain that caused recurrence by using emm-typing and PFGE-typing. To confirm if the recurrence is due to reinfection caused by a newly acquired strain from the community, we also investigated the changes in the emm and PFGEtypes of the relevant GAS strains within the community during the study period.
METHODS
Bacterial strains and culture A total of 135 GAS clinical strains were analysed in this study. These strains were isolated from the tonsils of 116 pediatric patients with acute GAS pharyngitis at Hirose Children's Clinic, a fixed-point of infection surveillance, in Saga, Japan, between November, 2012 and April, 2014.
Nineteen strains were obtained from 19 recurrent cases (17 patients) who were treated with 10 days oral amoxicillin (AMPC) for their initial pharyngitis. The diagnosis of the primary and recurrent GAS pharyngitis was distinguished from the carriage state on the basis of both positive throat culture and the following clinical features: the GAS pharyngitis showed symptoms of sudden fever, headache, sore throat, cervical lymphadenopathy, and sometimes abdominal pain and sandpaper-like erythematous rash with itching (also called as 'scarlet fever'). The GAS pharyngitis was not accompanied by cough and rhinorrhea. Exudative tonsillitis, reddened soft palate and strawberry tongue were manifestations [3] .
The bacteria were cultured in Todd Hewitt broth (Becton, Dickinson and Company, USA) with 0.5 % Yeast Extract (Becton, Dickinson and Company, USA) (THY broth) at 37 C without shaking under aerobic conditions for 18 h.
DNA extraction
For DNA extraction, the cultures of isolates were harvested by centrifugation (16 000 g) for 3 min at 4 C. Genomic DNA was extracted using the Illustra Bacteria GenomicPrep mini spin kit (GE Healthcare, United Kingdom) according to the protocol designated for Gram-positive bacteria.
M protein gene (emm) typing PCR amplification and DNA sequencing were performed according to the protocol for M protein gene (emm) typing from the US Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/streplab/protocol-emm-type. html) [15, 16] . To identify the emm-types of the isolates, the DNA sequences of the emm genes were entered into the Streptococci Group A Subtyping Request Form (BLAST 2.0 server) of CDC (http://www2a.cdc.gov/ncidod/biotech/ strepblast.asp) and submitted through the CDC website. The results of the emm-types were reported immediately by e-mail. The emm-types are described as the type level in this paper (e.g. emm 4.4 is described as emm 4) [15] .
Pulsed-field gel electrophoresis (PFGE) typing
For pulsed-field gel electrophoresis (PFGE) analysis, the bacterial suspension was mixed with a melted 1 % SeaKem Gold Agarose (Lonza, Rockland, ME) at a concentration of 10 9 cells ml À1 . The bacteria-agarose mixture was immediately dispensed into the wells of a disposable plug mold (Bio-Rad Laboratories Inc., CA) and allowed to solidify. The agarose plugs were incubated in 100 mM EDTA (pH 8.0) containing 1 mg of lysozyme per ml at 37 C for 2 h by mixing at 15 min intervals. The plugs were then incubated in 250 mM EDTA (pH 8.0) containing 1 mg of proteinase K per ml and 1 % sodium dodecyl sulfate (SDS) at 50 C for 4 h. The plugs were subsequently transferred to a phenylmethylsulfonyl fluoride (PMSF) solution (40 µg ml À1 in TE buffer, pH 7.6) and incubated twice at 50 C for 30 min. The plugs were then washed with a TE buffer (pH 8.0) once. The extracted DNA was digested overnight with 25 units of SmaI (Toyobo Co. Ltd., Japan) in a 30 C incubator. If any DNA was not digested with SmaI, 30 units of SfiI (Takara Bio Inc., Japan) were used and it was incubated overnight at 50 C [17, 18] .
PFGE was performed in 0.5ÂTBE buffer in a contourclamped homogeneous electric field apparatus (CHEF-DR II apparatus; Bio-Rad Laboratories Inc., CA). Portions of the agarose plugs containing SmaI or SfiI-digested DNA were embedded in 1 % PFGE agarose gel (Bio-Rad Laboratories Inc., CA). Electrophoresis was performed at 14 C for 24 h at 6.0 V cm À1 with a ramped pulse time of 5 to 25 s. After electrophoresis, the gels were stained with 1 mg l À1 of ethidium bromide and the DNA bands were observed on a UV transilluminator [17, 18] .
AMPC susceptibility
Minimal inhibitory concentrations (MICs) against AMPC for GAS isolates were determined by a microdilution method [19] . Briefly, each isolate was inoculated into THY broth containing two-fold serial dilutions of AMPC (final concentrations ranged from 0.0075 to 0.5 µg ml
À1
) in 96-well microtiter plates. The bacterial inoculation in each well was 5Â10 4 colony forming units (c.f.u.). The plates were incubated at 37 C overnight, and the MIC was defined as the lowest concentration of the antibiotic that prevented visible growth.
For antimicrobial tolerance assay, 1Â10 9 cells of GAS strains isolated from the recurrent cases were suspended in 1 ml of THY with or without 0.5 µg of AMPC and incubated at 37 C. Once a day during the 10 days after the inoculation, the samples were centrifuged at 6000 g for 10 min, and the pellets were re-suspended into fresh THY broth with or without AMPC to maintain the antimicrobial activity. After the incubation for 10 days, the samples were centrifuged and washed with PBS to eliminate AMPC. After serial 10-fold dilution of the suspension with PBS, 0.1 ml was plated onto blood agar. The plates were incubated at 37 C, and colony forming units (c.f.u.) were counted after 18 h [19] .
The index of discrimination powers (ID)
The index of discrimination powers (ID) for emm typing and PFGE typing was calculated by the method of Hunter and Gaston [20, 21] , which is based on the probability that two unrelated strains sampled from a test population will be placed into different groups by the typing method [22] . An ID of 1.0 would indicate that the typing method is able to distinguish each strain from all other members of the test population. Conversely, an ID of 0.0 would indicate that all the strains of the test population were of an identical type [22] .
Statistical analysis
Fisher's exact test was used to evaluate the difference between each group in the proportion of reactivation among recurrence.
Ethical consideration
The study was approved by the Ethics Committee of Medical Research, University of Occupational and Environmental Health, Japan (No. H29-053). Informed consent was obtained from the parents of each patient.
RESULTS
emm typing and PFGE typing of isolates A total of 135 GAS clinical strains were isolated from the tonsils of 116 pediatric patients with acute pharyngitis, and analysed by molecular typing methods. The isolates belonged to nine emm types (emm 1, 4, 6, 9, 12, 28, 63, 75 and 89). In PFGE analysis, the DNA of 104 strains was digested by SmaI enzyme, and their restriction patterns were grouped into 13 types, named as B 1 , B 3 , C 1 , C 2 , D, E 1 , E 2 , F 1 , F 2 , F 3 , G, I 1 and I 2 . The remaining 31 strains showed 3 types of defined fingerprint patterns (A, B 2 , and H) by using SfiI enzyme. Finally, the clinical isolates were grouped into 16 PFGE types (Fig. 1) . In this study, emm 6, 12, and 89 included two PFGE patterns each, and emm 4 and 28 included three PFGE patterns each. There was no overlapping PFGE pattern among the multiple emm-types. Based on these results, it can be said that PFGE analysis can distinguish strains belonging to the same emm-type in more detail than emm typing can. In this study, the index of discrimination powers for emm typing and PFGE typing were calculated to be 0.067 and 0.119, respectively.
Shift in GAS isolates during the study period
The numbers of each PFGE-type of GAS isolated during each two month period from November, 2012 to April, 2014 are shown in Fig. 2 . During the cold season (November -March), more GAS strains were isolated from acute pharyngitis patients than during the hot season (JulyAugust), similar to the prevalence found in temperate regions [11] . The strains of emm 4 (PFGE-type B 1-3 ), emm 12 (PFGE-type E 1, 2 ), and emm 28 (PFGE-type F 1-3 ) were always dominant throughout the study period. The combination of emm typing and PFGE analysis revealed that the major PFGE type of isolates belonging to emm 4 changed from B 1 through B 2 to B 3 during the eighteen month duration of the study. Among the emm 28 strains, only the PFGE-type F 1 strains were isolated in the beginning of the study period, but F 2 and F 3 strains emerged after September 2013. No PFGE-type A strains belonging to emm 1 were isolated from May 2013 to February 2014, but they reemerged in March 2014. PFGE type C 1 and C 2 strains belonging to emm 6 began to be isolated at the end of 2013, and increased in number in 2014.
PFGE analysis of the strains isolated from the recurrent cases
In this study, there were 19 recurrent cases among 17 patients after 10 days treatment with oral AMPC. Two out of the 17 patients suffered from recurrent pharyngitis twice. In total, 19 pairs of primary and recurrent strains were obtained from all the recurrent cases, and were analysed by PFGE to clarify whether the isolates of primary and recurrent infection were distinguishable from each other or not per individual case. The results are shown in Fig. 3 . In 13 cases, the primary and recurrent strains belonged to the same PFGE-type as well as to the same emm-type. These recurrent cases were thought to be 'reactivation' caused by the primary strain surviving treatment with antibiotics. In the remaining six cases, the PFGE-types of the recurrent strains were different from those of the primary strains. The PFGE types of these recurrent strains (B 2 , C 2 , F 1 , H, I 1 , belonging to emm 4, 6, 28, 75, 89, respectively) were also observed in other patients of the study population in the same period. Therefore, these recurrent cases were thought to be 'reinfection' caused by newly acquired strains.
Nineteen recurrent cases could be sharply divided into two groups according to the time to recurrence: a short interval (within 40 days) group, and a long interval (more than 40 days) group. There were 11 recurrent cases that occurred within 40 days after the last treatment of 10 day oral AMPC ( Table 1 ). The average interval of these cases was 27.1 days. Notably, all of them were reactivation. The strains that caused reactivation were the PFGE-types A, B 2 , C 1 , E 1 , and F 1 , belonging to emm 1, 4, 6, 12, 28, respectively (Fig. 3) . The remaining eight recurrent cases occurred more than 40 days after the last oral AMPC treatment, with an average interval of 271 days. Two of these were reactivation and the other six were reinfection (Table 1) . Thus, there was a trend toward a higher frequency of reinfection in recurrent cases occurring more than 40 days after the last treatment (6 of 8 vs 0 of 11, P<0.001).
The antibiotics failure rate, which is estimated by dividing the number of total cases treated with the antibiotics by the number of reactivation cases, was 11.0 % (13/118). This result concurred with a previous report (5-30 %) [7] .
AMPC susceptibility of the isolates
The MICs of AMPC for the isolates were 0.015 µg ml À1 in all of the 16 PFGE types. Among the 12 reactivation cases, the MICs of AMPC for both the primary and recurrent isolates were equivalent (0.015 µg ml À1 ). It is concluded that the surviving strains isolated from the reactivation cases were not resistant to AMPC.
To clarify whether the surviving strains were tolerant to AMPC or not, the 12 strains isolated from the reactivated cases were exposed to the actual blood AMPC level (5 µg ml À1 of blood) during oral medication (30 mg per kg per day) for 10 days [23] . As a result, all the strains became unculturable within five days. After 10 days of exposure to AMPC, the 12 strains were incubated in THY broth without AMPC, but they did not grow. This in vitro assay could not confirm an AMPC tolerance of the strains that caused reactivated GAS pharyngitis.
DISCUSSION
The epidemic GAS strains causing acute pharyngitis in the pediatric population of the community in this study changed dynamically during the 18 months study period. A variety of emm-types was always observed among the epidemic strains, and each type showed different emerging trends. Some emm-types (emm 4, 12, 28) were dominant constantly throughout the study period, whereas others emerged for only a short time. PFGE typing had a higher Fig. 1 . emm typing and PFGE typing of GAS isolates in this study. A total of 135 GAS isolates belonged to nine emm-types (emm1, 4, 6, 9, 12, 28, 63, 75 and 89). The DNA of 104 strains was digested by SmaI enzyme, and their restriction patterns were grouped into 13 types, namely B 1 , B 3 , C 1 , C 2 , D, E 1 , E 2 , F 1 , F 2 , F 3 , G, I 1 and I 2 . The DNA of the remaining 31 strains was not digested with SmaI, but showed 3 types of defined fingerprint patterns (A, B 2 , and H) by using SfiI. Finally, the clinical isolates were grouped into 16 PFGE types. The strains of emm 6, 12, and 89 included two PFGE patterns each, and the strains of emm 4 and 28 included three PFGE patterns each. There was no overlap of the same PFGE pattern among the multiple emm-types. discrimination power than emm typing, and could distinguish some strains belonging to the same emm-type. Although a previous report described the shift of emm-types of epidemic GAS strains, our study demonstrated that the combination of emm typing with PFGE typing provided more detailed epidemiological information on GAS infection. It was revealed, for example, that emm 4 strains appeared constantly but their PFGE type gradually changed during the study period.
In the 11 recurrent cases that occurred within 40 days after the last oral AMPC treatment, each strain that was isolated from the patients' tonsils showed the same PFGE-type as the primary strain, whereas in six out of the eight recurrent cases that happened more than 40 days after the last treatment, the recurrent strains showed different PFGE-and emm-types in every case. The remaining two reactivation cases were caused by PFGE-type F 1 (Fig. 3) . There is a possibility that the recurrent strains belonging to PFGE-type F 1 were acquired from the community again after the primary strain F 1 had been eradicated, because PFGE-type F 1 was isolated at all times throughout the study period (Fig. 2) . Based on these results, we assumed that the recurrence of GAS infection within 40 days after the last treatment was caused by the primary GAS strain remaining at the infection site (i.e. reactivation), and that the recurrence of GAS infection more than 40 days after the treatment was caused by a newly acquired GAS strain from the community (i.e. reinfection).
In this study, the twelve strains that caused reactivation belonged to four PFGE-types, namely A, B 2 , C 1 , E 1 and F 1 , and they were sensitive to AMPC. This suggested that the acquisition of antibiotic resistance in GAS was not the cause of reactivation. The mechanisms for the reactivation have been described in some papers as follows: (1) GAS may invade nonphagocytic cells and persist intracellularly, where they may be protected from both antibiotic therapy and human immune response [1, 24, 25] ; (2) Some GAS cells may become tolerant to antibiotics and survive the exposure to penicillin during 10 days [19, 26, 27] . In this study however, an AMPC tolerance of the strains that caused reactivation was not observed; (3) GAS cells may form a biofilm which reduces susceptibility to penicillin and host immune defenses; (4) Some non-pathogenic bacteria colonising the tonsils produce b-lactamase, which provides penicillin resistance by breaking the structure of the b-lactam ring; and (5) GAS cells may survive due to reduced compliance with oral penicillin therapy. However, all the subjects in this study were checked for treatment compliance.
The reasons why GAS reinfection, on the other hand, often occurs have been explained as follows: 1) The M protein of GAS acts as the primary antigen and induces type-specific Fig. 2 . Shift in GAS isolates during the study period. The numbers of each PFGE type of GAS isolated during each two months are shown. The names of the PFGE types are the same as in Fig. 1. immunity. As M proteins are antigenically hypervariable, the antibody against one M type may not develop a crossimmune reaction to other M types; 2) Protective immunity against GAS may not be induced as a result of early penicillin treatment; 3) There are always GAS carriers at day-care centers and primary schools, and GAS may often be transmitted by close child-to-child contact in such facilities; and 4) The penicillin treatment for GAS infection changes the normal bacterial flora in the pharynx, making it easier for the GAS organisms to colonise again.
The present study has enabled us to understand whether recurrent pharyngitis is a reactivation caused by the primary strain or a reinfection caused by a newly acquired strain. The results of this study could help pediatricians to decide the appropriate treatment for patients with recurrent pharyngitis. When the recurrent pharyngitis appears more than 40 days after the last treatment, penicillin can be chosen again because it is suspected to be a reinfection. On the other hand, when the recurrent pharyngitis occurs within 40 days after completing the treatment, the maximum dose of penicillin, or alternative drugs such as narrow-spectrum cephalosporin, amoxicillin-clavulanate potassium, clindamycin, erythromycin, or other macrolides should be considered for retreatment [3] . Amoxicillin-clavulanate potassium is expected to be effective against GAS coexisting with blactamase-producing bacteria. Macrolides may be effective against intracellular GAS, but extra precaution is also required because GAS strains resistant to macrolide are prevalent in some areas of the world [3] .
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